Tag: Cancer Drugs

Russian scientists developed 26 innovative cancer drugs

These drugs should improve the quality of life for the patients, including those with advanced forms of cancer

FDA recommended approval of Novartis CAR-T cell therapy

US Food and Drug Administration Oncologic Drugs Advisory Committee unanimously recommended approval of CTL019

Daiichi Sankyo will collaborate with Max Planck Innovation and Lead Discovery Center

Daiichi Sankyo, Max Planck Innovation GmbH and the Lead Discovery Center GmbH have signed an agreement providing Daiichi Sankyo with the option to receive the exclusive rights to a new lead compound for the treatment of cancer

NatiVita from Belarus will begin to test its cancer drugs this fall

In fall of 2017, JLLC NatiVita will begin studies of innovative drugs for the treatment of skin and breast cancer

Celgene started collaboration with BeiGene

U.S. biopharmaceutical company Celgene Corp. plans to acquire an equity stake in Chinese peer BeiGene Ltd.

Hetero Labs Ltd. comes from India to Tula region

A new plant to manufacture the substance for AIDS drugs and oncological medicines will appear in the Tula region on the premises of Sintvita

Eisai plans to receive approval for its cancer drug in China

cancer drugs
Eisai, a Japanese pharmaceutical company, intends to apply in China as soon as October for marketing approval for its new liver cancer drug Lenvima

Valeant Pharmaceuticals sold Dendreon to Sanpower Group

Sanpower Group, a Chinese private conglomerate, said it had completed its 100 percent acquisition of Dendreon Pharmaceuticals

Preclinical trials of oncoprotein with iron oxide nanoparticle start in Russia

The researchers at the National University of Science and Technology MISiS, Moscow State University and Medical Nanotechnology LLC have begun preclinical trials of a Russian drug for the treatment of cancerous tumors.

Chi-Med and AstraZeneca start phase III trial of kidney cancer drug

Chi-Med and AstraZeneca announced the initiation of a global pivotal Phase III, open-label, randomized multi-center registration study

Zykadia by Novartis obtained EU approval for first-line use

Novartis today announced the European Commission approved expanding the use of Zykadia

Innovative domestically produced cancer drugs are expected in the Russian market

In the future, new domestically produced drugs designed for the therapy of patients with oncological diseases will be available on the Russian market

Scientists in Siberia develop cancer drugs from living viruses

The researchers at the Novosibirsk Academgorodok and Research Center of Virology and Biotechnology VECTOR are developing drugs for the treatment of oncological diseases

R-Pharm and Aspyrian Therapeutics signed an exclusive licensing agreement

R-Pharm Overseas, Inc., a division of R-Pharm Group, signed an exclusive licensing agreement with Aspyrian Therapeutics Inc.

Novartis breast cancer drug received positive CHMP opinion

Novartis today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of Kisqali

Merck KGaA creates spinout company iOnctura

Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced its corporate venture arm created iOnctura SA, Geneva, Switzerland